STOCK TITAN
  1. Home
  2. Sec-filings
  3. AGX
  4. [Form 4] ARGAN INC Insider Trading Activity

Argan Inc. (AGX) director William Leimkuhler exercises multiple stock options

Filing Impact
(Very High)
Filing Sentiment
(Positive)
Form Type
4

Rhea-AI Filing Summary

Argan Inc. director William F. Leimkuhler reported multiple stock option exercises in the company’s common stock. On January 7, 2026, he exercised options granted between December 2019 and December 2022 to purchase blocks of 10,000 and 5,000 shares at exercise prices of $40.15, $45.75, $37.13, and $35.72 per share, using the net settle method. These exercises increased his directly held common stock, and following the reported transactions he directly owned 67,359 Argan shares.

Positive

  • None.

Negative

  • None.
Insider Leimkuhler William F.
Role Director
Type Security Shares Price Value
Exercise Option to Purchase Common Stock 10,000 $40.15 $402K
Exercise Option to Purchase Common Stock 10,000 $45.75 $458K
Exercise Option to Purchase Common Stock 5,000 $37.13 $186K
Exercise Option to Purchase Common Stock 5,000 $35.72 $179K
Exercise Common Stock 8,794 $40.15 $353K
Exercise Common Stock 8,626 $45.75 $395K
Exercise Common Stock 4,442 $37.13 $165K
Exercise Common Stock 4,463 $35.72 $159K
Holdings After Transaction: Option to Purchase Common Stock — 21,500 shares (Direct); Common Stock — 49,828 shares (Direct)
Footnotes (1)
  1. On January 7, 2026, the Reporting Person exercised his stock option awarded on December 23, 2019 to purchase 10,000 shares of the Issuer's common stock at a price of $40.15 per share, using the net settle method. On January 7, 2026, the Reporting Person exercised his stock option awarded on December 14, 2020 to purchase 10,000 shares of the Issuer's common stock at a price of $45.75 per share, using the net settle method. On January 7, 2026, the Reporting Person exercised his stock option awarded on December 14, 2021 to purchase 5,000 shares of the Issuer's common stock at a price of $37.13 per share, using the net settle method. On January 7, 2026, the Reporting Person exercised his stock option awarded on December 16, 2022 to purchase 5,000 shares of the Issuer's common stock at a price of $35.72 per share, using the net settle method.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Leimkuhler William F.
(Last) (First) (Middle)
43 SALEM STRAITS ROAD
(Street)
DARIEN CT 06820
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
ARGAN INC [ AGX ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
01/07/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 01/07/2026 M 8,794(1) A $40.15 49,828 D
Common Stock 01/07/2026 M 8,626(2) A $45.75 58,454 D
Common Stock 01/07/2026 M 4,442(3) A $37.13 62,896 D
Common Stock 01/07/2026 M 4,463(4) A $35.72 67,359 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Option to Purchase Common Stock $40.15 01/07/2026 M 10,000(1) 12/23/2020 12/23/2029 Common Stock 10,000 $40.15 21,500 D
Option to Purchase Common Stock $45.75 01/07/2026 M 10,000(2) 12/14/2021 12/14/2030 Common Stock 10,000 $45.75 11,500 D
Option to Purchase Common Stock $37.13 01/07/2026 M 5,000(3) 12/14/2022 12/14/2031 Common Stock 5,000 $37.13 6,500 D
Option to Purchase Common Stock $35.72 01/07/2026 M 5,000(4) 12/16/2023 12/16/2032 Common Stock 5,000 $35.72 1,500 D
Explanation of Responses:
1. On January 7, 2026, the Reporting Person exercised his stock option awarded on December 23, 2019 to purchase 10,000 shares of the Issuer's common stock at a price of $40.15 per share, using the net settle method.
2. On January 7, 2026, the Reporting Person exercised his stock option awarded on December 14, 2020 to purchase 10,000 shares of the Issuer's common stock at a price of $45.75 per share, using the net settle method.
3. On January 7, 2026, the Reporting Person exercised his stock option awarded on December 14, 2021 to purchase 5,000 shares of the Issuer's common stock at a price of $37.13 per share, using the net settle method.
4. On January 7, 2026, the Reporting Person exercised his stock option awarded on December 16, 2022 to purchase 5,000 shares of the Issuer's common stock at a price of $35.72 per share, using the net settle method.
/s/ William F. Leimkuhler 01/09/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

Who is the insider involved in this Argan Inc. (AGX) Form 4 filing?

The insider is William F. Leimkuhler, who serves as a director of Argan Inc. He is not listed as an officer or 10% owner in this filing.

What transactions did Argan Inc. (AGX) director William Leimkuhler report on January 7, 2026?

On January 7, 2026, William Leimkuhler reported exercising four stock options to acquire Argan common stock, with each transaction coded “M” (option exercise) in the Form 4.

What were the option exercise prices disclosed in this Argan (AGX) Form 4?

The options were exercised at prices of $40.15, $45.75, $37.13, and $35.72 per share, as shown in both the transaction tables and the explanatory footnotes.

How many Argan (AGX) shares were tied to each stock option exercise?

The filing states that options to purchase 10,000 shares were exercised at $40.15 and $45.75 per share, and options to purchase 5,000 shares were exercised at $37.13 and $35.72 per share.

How many Argan Inc. (AGX) shares does William Leimkuhler own after these transactions?

After the reported transactions on January 7, 2026, the Form 4 shows that William Leimkuhler directly owns 67,359 shares of Argan common stock.

What method was used to exercise the Argan (AGX) stock options in this Form 4?

The explanatory footnotes state that each option exercise on January 7, 2026 was completed using the net settle method.